Thermo Fisher Scientific Inc.
Strong FundamentalsStrong FundamentalsRevenue growing 6% YoY at strong marginsStreet coverage with positive forward estimatesQuiet on X (96 mentions/wk)$617.10-0.8%YTD-2.5%1Y+26.6%
Mentions · last 7 days
96+2%
Price updated 11h ago·X counts updated 9d ago
AI verdict & sentimentAI analysisGenerated by AI from underlying data
Today's AI verdict on what's driving $TMO, plus how loud the X conversation is and which way it's leaning.
What it does
Plain-English summary of the business — what they sell and how they make money.
Industry overviewAI analysisGenerated by AI from underlying data
Where Medical - Diagnostics & Research sits in its cycle right now — and what that implies for $TMO.
Medical - Diagnostics & Research
Diagnostic testing volumes are normalizing post-COVID elevated baseline; liquid biopsy and genomic sequencing are the structural growth areas. Reimbursement rate changes (CMS updates) are the primary margin risk for established lab businesses.
What this means for $TMO
Partial — upstream oil & gas exposure ties to commodity price cycle; Thermo Fisher Scientific Inc.
Industry benchmark
21-name peer basket
+37.3%YTD
+75.3%1Y
Fundamentals & catalyst
Profitability, valuation, and the next earnings event — at a glance, with rule-of-thumb signals.
Key ratios
P/E
25.6How much investors are paying per dollar of profit the company actually earned in the last 12 months. Lower means the stock looks cheaper relative to earnings.~15–25 is typical for the S&P 500; high-growth names trade 30+; hyper-growth or speculative can be 100+ or negative.ROIC
7.3%What percentage return the business earns on every dollar of capital (equity + debt) deployed in operations. The cleanest measure of business quality.Above ~15% is high-quality; consistently above 25% suggests a real moat. Below the company's cost of capital is value-destroying.Op margin
17.8%Operating profit (after sales, marketing, R&D, and overhead but before interest and taxes) as a percentage of revenue. The clearest view of how well the underlying business is run.Mature business above 20% is healthy; software businesses can run 30%+; commodity / retail businesses operate in single digits.FCF yield
3.8%Free cash flow (operating cash flow minus capex) divided by the company's market cap. The cash-on-cash return you'd get owning the whole business at today's price.Above ~5% is attractive; below ~2% means you're paying up for growth. Capital-light businesses (software) run higher than capital-heavy ones (utilities).P/S
3.9Same idea as P/E but per dollar of revenue. Useful for companies that aren't profitable yet, where P/E is meaningless.Under ~2 is cheap; software / SaaS often runs 8–15; well above 20 implies the market is pricing in very high future growth.ROE
13.3%Net income as a percentage of shareholders' equity. Similar to ROIC but counts only the equity side.Above 20% is strong, but can be inflated by leverage — a heavily indebted company can show high ROE with weak underlying ROIC.Gross margin
39.4%Revenue minus the direct cost of producing what was sold, as a percentage of revenue. The first read on whether the product is structurally profitable.Software / SaaS is typically 70%+; consumer goods 30–50%; commodity / hardware businesses can be under 20%.D/E
0.8Total debt divided by shareholders' equity. Measures how much the business runs on borrowed money versus owner capital.Under 1 is conservative; 1–2 is typical for mature businesses; over 2 is leveraged and more sensitive to interest rates.Past earnings
QuarterReportedActualEstimateSurprise
Q2 2026Jul 23, 2026$6.03$5.72+5.4%
Q1 2026Apr 23, 2026$5.44$5.25+3.6%
Q4 2025Jan 29, 2026$6.57$6.45+1.9%
Q3 2025Oct 22, 2025$5.79$5.50+5.3%
Next earningsWed, Oct 28·consensus EPS $6.40
Quarterly trend
QuarterRevenueYoYGrossOpEPSFCF
Q1 FY26$11.0B+6.2%40.7%16.9%$4.44$816.0M
Q4 FY25$12.2B+7.2%38.0%18.8%$5.22$3.0B
Q3 FY25$11.1B+4.9%41.8%17.5%$4.28$1.8B
Q2 FY25$10.9B+3.0%37.3%17.7%$4.28$1.1B
Forward consensus
FYRevenueRangeEPSRangeAnalysts
FY26$47.8B$47.6B – $47.9B$25.01$24.79 – $25.1819
FY27$50.3B$48.8B – $51.0B$27.31$26.37 – $28.0220
FY28$53.4B$52.5B – $54.4B$30.16$27.43 – $32.5116
FY29$56.6B$55.8B – $57.2B$33.96$33.38 – $34.4015
FY30$58.5B$57.7B – $59.1B$38.14$37.49 – $38.6415
Setup & momentum
Volume, range, and moving-average position — the technical setup driving short-term moves.
Right now
Vol vs 30dToday's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.0.5×Today's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.
52w rangeWhere the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.88%Where the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.
vs 50d MALatest close vs the 50-day simple moving average. Positive = short-term trend is up.+11.6%Latest close vs the 50-day simple moving average. Positive = short-term trend is up.
vs 200d MALatest close vs the 200-day simple moving average. Positive = long-term trend is up.+16.2%Latest close vs the 200-day simple moving average. Positive = long-term trend is up.
Float & profile
FloatHigh float · 370.7M shFree-float shares — the slice of issued stock actually available to trade. Lower buckets squeeze harder on a catalyst.Traded today0.3% of floatToday's volume as a percent of the free float. Above 5% on a single day is unusually high turnover for the available share count.β0.855-year weekly beta vs the S&P 500. Above 1.5 means the stock typically moves more than the index; below 0.8 moves less.
Insider activity
Recent open-market buys and sells by officers and directors — flagged when multiple insiders cluster.
SEC filings
Material 8-K, 13D, S-3, and 424B5 events from the last 180 days — the filings that actually move the price.
Recent material filings
8-KShareholder voteMay 268-K — Item 5.07: Shareholder vote
AI summary
+ 13 other (3 proxys · 2 10-Qs · 2 earnings 8-Ks · 2 13Gs) in window
Recent news
Latest headlines from major outlets, sourced and timestamped — context for whatever just moved.
37,709 Shares in Thermo Fisher Scientific Inc. $TMO Purchased by Beacon Pointe Advisors LLCAusdal Financial Partners Inc. Makes New $456,000 Investment in Thermo Fisher Scientific Inc. $TMOBank OZK Takes $1.10 Million Position in Thermo Fisher Scientific Inc. $TMOThermo Fisher Scientific Introduces the Thermo Scientific™ EMPAD™ G2 Electron Detector to Advance Materials ResearchDelta Air, Target, Thermo Fisher Scientific And A Financial Stock On CNBC's ‘Final Trades'
In themes
Explore the broader themes this ticker is being talked about under.
More in Medical - Diagnostics & Research
Peers in the same group — one click to compare setups, fundamentals, and chatter.
Voices on X · top 4 · last 7 days